CN111574392A - A kind of preparation method of 6-desmethyl-6-anhydrotetracycline - Google Patents
A kind of preparation method of 6-desmethyl-6-anhydrotetracycline Download PDFInfo
- Publication number
- CN111574392A CN111574392A CN202010461654.XA CN202010461654A CN111574392A CN 111574392 A CN111574392 A CN 111574392A CN 202010461654 A CN202010461654 A CN 202010461654A CN 111574392 A CN111574392 A CN 111574392A
- Authority
- CN
- China
- Prior art keywords
- anhydrotetracycline
- demethyl
- demethyltetracycline
- water
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 31
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000003756 stirring Methods 0.000 claims abstract description 22
- RMVMLZHPWMTQGK-SOUFLCLCSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=CC=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O RMVMLZHPWMTQGK-SOUFLCLCSA-N 0.000 claims abstract description 19
- JCSGAUKCDAVARS-UHFFFAOYSA-N demethyltetracycline Natural products CN(C1C(=C(C(C2(C(=C3C(C4=C(C=CC=C4C(C3CC12)O)O)=O)O)O)=O)C(=O)N)O)C JCSGAUKCDAVARS-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000001257 hydrogen Substances 0.000 claims abstract description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004202 carbamide Substances 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 239000008213 purified water Substances 0.000 claims abstract description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract 6
- QYAPHLRPFNSDNH-MRFRVZCGSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical class Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-MRFRVZCGSA-N 0.000 claims abstract 4
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 claims abstract 3
- 230000001737 promoting effect Effects 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 6
- -1 demethyl aureomycin hydrochloride Chemical compound 0.000 claims description 5
- 239000012065 filter cake Substances 0.000 claims description 5
- 239000008234 soft water Substances 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 3
- 238000002156 mixing Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 9
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 abstract description 4
- 229930101283 tetracycline Natural products 0.000 abstract description 4
- 239000013558 reference substance Substances 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229960002398 demeclocycline Drugs 0.000 description 4
- FMTDIUIBLCQGJB-SEYHBJAFSA-N demeclocycline Chemical compound C1([C@@H](O)[C@H]2C3)=C(Cl)C=CC(O)=C1C(=O)C2=C(O)[C@@]1(O)[C@@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FMTDIUIBLCQGJB-SEYHBJAFSA-N 0.000 description 4
- GVSJQNRGSCOSNJ-KBHRXELFSA-N demeclocycline hydrochloride Chemical compound Cl.C1([C@@H](O)[C@H]2C3)=C(Cl)C=CC(O)=C1C(=O)C2=C(O)[C@@]1(O)[C@@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C1=O GVSJQNRGSCOSNJ-KBHRXELFSA-N 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- XDVCLKFLRAWGIT-ADOAZJKMSA-N sancycline Chemical compound C([C@H]1C2)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O XDVCLKFLRAWGIT-ADOAZJKMSA-N 0.000 description 3
- 229950000614 sancycline Drugs 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种6-去甲基-6-脱水四环素的制备方法。The present invention relates to a preparation method of 6-demethyl-6-anhydrotetracycline.
背景技术Background technique
6-去甲基-6-脱水四环素,是合成山环素过程中产生的主要杂质之一,其分子结构如下:6-Demethyl-6-anhydrotetracycline is one of the main impurities produced in the process of synthesizing sancycline. Its molecular structure is as follows:
6-去甲基-6-脱水四环素属于脱水四环素(Anhydrotetracycline),毒性大,抗菌活性差。传统制备方法是在山环素粗品中进行过柱或者制备色谱提纯,操作繁琐,而且单次制备的量较少。随着中国药典、美国药典和欧洲药典中对杂质的要求越来越严格,以及对杂质毒性和转化方向的研究不断深入,对标准品杂质的需求也逐渐增加,因此制备出高纯度,高含量的大样杂质对照品显得越来越重要。6-Demethyl-6-anhydrotetracycline belongs to Anhydrotetracycline with high toxicity and poor antibacterial activity. The traditional preparation method is to purify the crude sancycline by column or preparative chromatography, which is cumbersome to operate, and the amount of single preparation is small. As the requirements for impurities in the Chinese Pharmacopoeia, the US Pharmacopoeia and the European Pharmacopoeia become more and more stringent, and the research on the toxicity and transformation direction of impurities continues to deepen, the demand for standard impurities has gradually increased, so high-purity, high-content impurities are prepared. The large sample impurity reference standard is becoming more and more important.
发明内容SUMMARY OF THE INVENTION
本发明主要解决的技术问题是提供了一种安全、工艺简单、反应专一,收率高,成本低廉的6-去甲基-6-脱水四环素的制备方法。The main technical problem solved by the present invention is to provide a preparation method of 6-desmethyl-6-anhydrotetracycline which is safe, simple in process, specific in reaction, high in yield and low in cost.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于包括下列步骤:Described a kind of preparation method of 6-demethyl-6-anhydrotetracycline, is characterized in that comprising the following steps:
1)首先,将去甲基金霉素盐酸盐加入到纯化水中,滴加氨水,调节pH至6~8,搅拌至全溶,再加入尿素和Pd/C催化剂,在0.3~1.5Mpa氢气压力、35~50℃温度下反应4~6小时,以进行脱除7-位氯的反应,生成6-去甲基四环素;1) First, add demethyl chlortetracycline hydrochloride into purified water, add ammonia water dropwise, adjust pH to 6-8, stir until completely dissolved, then add urea and Pd/C catalyst, under 0.3-1.5Mpa hydrogen pressure , 35~50 ℃ of temperature react for 4~6 hours, in order to carry out the reaction of removing 7-position chlorine, generate 6-desmethyltetracycline;
2)将6-去甲基四环素加入到醇类溶剂中,滴加强酸,搅拌溶清,在1~3MPa氮气压力、45~60℃温度下反应,促使6-去甲基四环素分子中的6-位羟基与5a-位氢结合形成水并脱除生成双键,得到6-去甲基-6-脱水四环素反应液;所得反应液经后处理得到6-去甲基-6-脱水四环素产品。2) Add 6-desmethyltetracycline into an alcohol solvent, add dropwise strong acid, stir to dissolve, and react at 1-3MPa nitrogen pressure and 45-60°C temperature to promote 6-desmethyltetracycline in the molecule. The -position hydroxyl group is combined with the 5a-position hydrogen to form water and remove the double bond to obtain a 6-desmethyl-6-anhydrotetracycline reaction solution; the obtained reaction solution is post-treated to obtain a 6-desmethyl-6-anhydrotetracycline product .
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于去甲基金霉素盐酸盐和尿素的投料质量比为1:1~3。The method for preparing 6-demethyl-6-anhydrotetracycline is characterized in that the mass ratio of demethyl chlortetracycline hydrochloride and urea is 1:1-3.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于所述Pd/C催化剂中,Pd成分的质量分数为7~10%;去甲基金霉素盐酸盐与Pd/C催化剂的投料质量比为1:0.01~0.1,优选为1:0.02~0.1。The method for preparing 6-desmethyl-6-anhydrotetracycline is characterized in that in the Pd/C catalyst, the mass fraction of the Pd component is 7-10%; The feeding mass ratio of the Pd/C catalyst is 1:0.01~0.1, preferably 1:0.02~0.1.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于步骤2)中,所述醇类溶剂为体积浓度85%~95%的有机醇水溶液,有机醇为C1~C4醇,优选为甲醇、乙醇或异丙醇;去甲基金霉素盐酸盐与所述醇类溶剂的投料质量比为1 : 2~4。The method for preparing 6-desmethyl-6-anhydrotetracycline is characterized in that in step 2), the alcohol solvent is an organic alcohol aqueous solution with a volume concentration of 85% to 95%, and the organic alcohol is C1~95%. C4 alcohol, preferably methyl alcohol, ethanol or isopropanol; The mass ratio of demethyl chlortetracycline hydrochloride and described alcoholic solvent is 1: 2~4.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于步骤2)中,强酸为浓硫酸、甲烷磺酸、对甲苯磺酸或氢氟酸;所述6-去甲基四环素和强酸的投料质量比1:0.2~2,优选为1 : 0.5~2。The method for preparing 6-demethyl-6-anhydrotetracycline is characterized in that in step 2), the strong acid is concentrated sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid or hydrofluoric acid; The mass ratio of methyltetracycline and strong acid is 1:0.2~2, preferably 1:0.5~2.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于反应液经后处理的步骤为:将反应液降温至-5~10℃,再逐滴缓慢滴加浓硫酸调节pH到1~2(以便6-去甲基四环素粗品以硫酸盐的形式结晶析出),搅拌结晶1~3 h后,过滤,滤饼加入到无水低级醇中,加入DMF,用氨水调节pH至7~8,于-5~5℃下保温搅拌1~3 h,即制得所述的6-去甲基-6-脱水四环素产品。The described preparation method of 6-desmethyl-6-anhydrotetracycline is characterized in that the post-processing step of the reaction solution is as follows: cooling the reaction solution to -5~10°C, and then slowly adding concentrated sulfuric acid drop by drop Adjust the pH to 1-2 (so that the crude 6-desmethyltetracycline crystallizes in the form of sulfate), stir and crystallize for 1-3 h, filter, add the filter cake to anhydrous lower alcohol, add DMF, and adjust with ammonia water The pH is adjusted to 7 to 8, and the mixture is kept at -5 to 5° C. and stirred for 1 to 3 h to obtain the 6-desmethyl-6-anhydrotetracycline product.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于6-去甲基四环素与DMF的投料质量比1:0.1~0.5。The method for preparing 6-demethyl-6-anhydrotetracycline is characterized in that the mass ratio of 6-demethyltetracycline to DMF is 1:0.1-0.5.
所述的一种6-去甲基-6-脱水四环素的制备方法,其特征在于以重量份数计,具体包括以下步骤:Described a kind of preparation method of 6-demethyl-6-anhydrotetracycline, it is characterized in that in parts by weight, specifically comprises the following steps:
1)在软水中加入1份去甲基金霉素盐酸盐,用氨水调节pH至6~8,搅拌溶清,再加入 1~3份的尿素混合均匀,加入0.015~0.025份Pd质量分数为7~10%的Pd/C催化剂,在0.3~1.5Mpa氢气压力、35~50℃温度下反应4~6小时,生成6-去甲基四环素;1) Add 1 part of demethyl chlortetracycline hydrochloride to soft water, adjust the pH to 6-8 with ammonia water, stir to dissolve, then add 1-3 parts of urea and mix evenly, add 0.015-0.025 parts of Pd mass fraction of 7~10% Pd/C catalyst, react at 0.3~1.5Mpa hydrogen pressure and 35~50℃ temperature for 4~6 hours to generate 6-desmethyltetracycline;
2)然后将得到的6-去甲基四环素加入到2~4份的体积浓度85%~95%的有机醇水溶液中,控温在0~5℃下,加入0.5~2份强酸,搅拌至全溶;在1~3Mpa的氮气压力下,45~60℃下反应3~5小时,促使6-去甲基四环素分子中的6-位羟基与5a-位氢结合形成水并脱除,得到6-去甲基-6-脱水四环素反应液;将所得反应液冷却到-5~10℃,滴加0.2~1份的浓硫酸,调节反应液pH至1~2,得到6-去甲基-6-脱水四环素硫酸盐;再将6-去甲基-6-脱水四环素硫酸盐加入到3~5份的无水低级醇中,冷却到0~5℃,加入0.1~0.5份的DMF,用氨水调节pH至7~8,保温搅拌2h,过滤得到的6-去甲基-6-脱水四环素产品。2) Then add the obtained 6-desmethyltetracycline into 2-4 parts of an organic alcohol aqueous solution with a volume concentration of 85%-95%, control the temperature at 0-5°C, add 0.5-2 parts of a strong acid, and stir until Completely soluble; under the nitrogen pressure of 1-3Mpa, react at 45-60 ℃ for 3-5 hours to promote the combination of the 6-position hydroxyl group and the 5a-position hydrogen in the 6-desmethyltetracycline molecule to form water and remove it to obtain 6-demethyl-6-anhydrotetracycline reaction solution; the obtained reaction solution is cooled to -5~10° C., 0.2~1 part of concentrated sulfuric acid is added dropwise, and the pH of the reaction solution is adjusted to 1~2 to obtain 6-demethylation -6-anhydrotetracycline sulfate; then add 6-demethyl-6-anhydrotetracycline sulfate to 3-5 parts of anhydrous lower alcohol, cool to 0-5 ℃, add 0.1-0.5 part of DMF, Adjust the pH to 7-8 with ammonia water, keep stirring for 2 hours, and filter the obtained 6-desmethyl-6-anhydrotetracycline product.
本发明的反应进程采用HPLC进行监控,在本发明的两步法反应过程中:第一步一般是以反应液中原料去甲基金霉素含量在0.5%以下,为反应结束;第二步一般是以反应液中原料6-去甲基四环素含量在1%以下,为结束反应。The reaction process of the present invention is monitored by HPLC, and in the two-step reaction process of the present invention: the first step is generally that the content of the raw material demethyl chlortetracycline in the reaction solution is below 0.5%, and the reaction ends; the second step is generally The reaction is terminated when the content of the raw material 6-demethyltetracycline in the reaction solution is less than 1%.
本发明的合成路线如下:The synthetic route of the present invention is as follows:
本发明取得的有益效果如下:The beneficial effects obtained by the present invention are as follows:
1、本发明的工艺过程简便,所制备的6-去甲基-6-脱水四环素可作为山环素生产中杂质定性、定量的对照品,也可为后续脱水四环素转化为脱氧四环素的研究提供大样。1. The technological process of the present invention is simple and convenient, and the prepared 6-demethyl-6-anhydrotetracycline can be used as a reference substance for qualitative and quantitative impurities in the production of sancycline, and can also be used for the subsequent research that anhydrotetracycline is converted into deoxytetracycline. Great sample.
2、本发明采用两步法,第一步制备6-去甲基四环素时,以尿素做缚酸剂,体系pH维持在6~8,减少了C环被破坏的发生,同时,尿素可与生成的6-去甲基四环素形成复盐,既提高收率又提高纯度。第二步制备6-去甲基-6-脱水四环素中,用氮气带压,促进了C6位的羟基与C5a位的氢脱去一分子水,精制时的DMF能够溶解大部分有机杂质,提高了6-去甲基-6-脱水四环素硫酸盐的纯度。2. The present invention adopts a two-step method. When preparing 6-demethyltetracycline in the first step, urea is used as an acid binding agent, and the pH of the system is maintained at 6 to 8, which reduces the occurrence of C ring being destroyed. The resulting 6-desmethyltetracycline forms a double salt, which improves both the yield and the purity. In the preparation of 6-desmethyl-6-anhydrotetracycline in the second step, nitrogen pressure was used to promote the removal of a molecule of water from the hydroxyl group at the C6 position and the hydrogen at the C5a position. The refined DMF can dissolve most of the organic impurities and improve the The purity of 6-desmethyl-6-anhydrotetracycline sulfate was determined.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步说明,但本发明的保护范围并不限于此。The present invention will be further described below with reference to specific embodiments, but the protection scope of the present invention is not limited thereto.
实施例1:Example 1:
将100g软水降温至25℃,加入27g去甲金霉素盐酸盐,用氨水调节pH至8.0,搅拌全溶后加入30g尿素,搅拌10分钟后将上述混合液和0.5g 10%Pd/C(折干后)投入到500ml的氢化反应釜中。先后用0.2MPa的氮气和0.2MPa的氢气分别置换3次,以排尽氢化反应釜中的空气。在1.0MPa的氢气压力下,控温在35~40℃,反应6h,中控至反应液中的原料去甲基金霉素含量为0.3%,反应结束,泄氢气,氮气置换三次。放料,降温至25℃,滴加质量浓度为36%的浓盐酸15g,搅拌15分钟待析出的物料完全溶解后,过滤Pd/C。收集滤液,滴加24g质量浓度为40%的液碱,于25℃保温析晶1h,抽滤,得6-去甲基四环素,烘干得19.6g,纯度98.5%,收率84.77%。Cool 100g of soft water to 25°C, add 27g of chlortetracycline hydrochloride, adjust the pH to 8.0 with ammonia, stir to dissolve completely, add 30g of urea, stir for 10 minutes, mix the above mixture and 0.5g of 10% Pd/C (After drying) put into a 500ml hydrogenation reactor. It was replaced with 0.2MPa nitrogen and 0.2MPa hydrogen three times respectively to exhaust the air in the hydrogenation reaction kettle. Under the hydrogen pressure of 1.0 MPa, the temperature was controlled at 35~40 °C, and the reaction was carried out for 6 h, and the content of the raw material demethyl chlortetracycline in the reaction solution was controlled to be 0.3%. The material was discharged, cooled to 25°C, 15 g of concentrated hydrochloric acid with a mass concentration of 36% was added dropwise, stirred for 15 minutes until the precipitated material was completely dissolved, and then Pd/C was filtered. The filtrate was collected, 24 g of liquid caustic soda with a mass concentration of 40% was added dropwise, crystallization at 25°C for 1 h, suction filtration to obtain 6-demethyltetracycline, and dried to obtain 19.6 g with a purity of 98.5% and a yield of 84.77%.
19.6g 6-去甲基四环素加入到100g体积浓度为85%的甲醇水溶液中,35℃内加入10g甲烷磺酸,溶解后投到500ml的高压釜中,用0.4MPa的氮气置换3次。在2.5MPa的氮气下,控温在45~50℃,中控至反应液中原料6-去甲基四环素含量为0.8%,反应结束,泄氮气。将得到的反应液降温至0℃,加入2g DMF,用98%浓硫酸调节pH到1,保温搅拌2h,过滤得湿料滤饼38.9g。湿料滤饼加入到60g无水甲醇中,再用氨水调节pH到7.5,于5℃下保温搅拌2h,过滤得高纯度6-去甲基-6-脱水四环素,烘干得15.1g黄色粉末,纯度94.2%,收率78%。19.6g of 6-demethyltetracycline was added to 100g of methanol aqueous solution with a volume concentration of 85%, 10g of methanesulfonic acid was added at 35°C, and after dissolving, it was put into a 500ml autoclave, and replaced 3 times with 0.4MPa nitrogen. Under the nitrogen gas of 2.5MPa, the temperature is controlled at 45~50°C, and the content of 6-desmethyltetracycline in the reaction solution is controlled to be 0.8%, the reaction is completed, and the nitrogen gas is released. The obtained reaction solution was cooled to 0°C, 2 g of DMF was added, the pH was adjusted to 1 with 98% concentrated sulfuric acid, stirred at a temperature for 2 h, and filtered to obtain 38.9 g of a wet cake. The wet filter cake was added to 60g of anhydrous methanol, and then adjusted to pH 7.5 with ammonia water, stirred at 5°C for 2h, filtered to obtain high-purity 6-desmethyl-6-anhydrotetracycline, and dried to obtain 15.1g of yellow powder , the purity is 94.2%, and the yield is 78%.
实施例2:Example 2:
将100g软水降温至25℃,加入30g去甲金霉素盐酸盐,用氨水调节pH至7.5,搅拌全溶后加入30g尿素,搅拌10分钟后将上述混合液和0.7g 10%Pd/C(折干后)投入到500ml的氢化反应釜中。先后用0.2MPa的氮气和0.2MPa的氢气分别置换3次。在0.8MPa的氢气压力下,控温在35~40℃,反应6h,中控至反应液中的原料去甲基金霉素含量为0.6%,反应结束,泄氢气,氮气置换三次。放料,降温至15℃,滴加质量浓度为36%的浓盐酸15g,搅拌至物料完全溶解后,过滤Pd/C。收集滤液,滴加质量浓度为40%的液碱28g,15℃保温析晶1h,抽滤,得6-去甲基四环素,烘干得20g,纯度97.1%,收率79.1%。Cool 100g of soft water to 25°C, add 30g of chlortetracycline hydrochloride, adjust the pH to 7.5 with ammonia, stir to dissolve completely, add 30g of urea, stir for 10 minutes, mix the above mixed solution and 0.7g of 10% Pd/C (After drying) put into a 500ml hydrogenation reactor. It was replaced three times with 0.2MPa nitrogen and 0.2MPa hydrogen respectively. Under the hydrogen pressure of 0.8MPa, the temperature was controlled at 35~40℃, and the reaction was carried out for 6h, and the content of the raw material demethyl chlortetracycline in the reaction solution was controlled to be 0.6%. The material was discharged, cooled to 15°C, 15 g of concentrated hydrochloric acid with a mass concentration of 36% was added dropwise, stirred until the material was completely dissolved, and the Pd/C was filtered. The filtrate was collected, 28 g of liquid caustic soda with a mass concentration of 40% was added dropwise, 15°C was kept for crystallization for 1 h, and suction filtered to obtain 6-desmethyltetracycline, which was dried to obtain 20 g, with a purity of 97.1% and a yield of 79.1%.
20g 6-去甲基四环素加入到100g体积浓度为85%的乙醇水溶液中,35℃内加入10g质量浓度为48%的氢溴酸水溶液,溶解后投到500ml的高压釜中,用0.2MPa的氮气置换3次。在2.0MPa的氮气下,控温在45~50℃,中控至反应液中原料6-去甲基四环素含量为0.6%,反应结束,泄氮气。将得到的反应液降温至0℃,用98%浓硫酸调节pH到1,保温搅拌2h,过滤得湿料滤饼42.0g。湿料滤饼加入到60g无水甲醇中,加入2.5g DMF,再用氨水调节pH到7.3,于5℃下保温搅拌2h,过滤得高纯度6-去甲基-6-脱水四环素,烘干得14.6g黄色粉末,纯度95.6%,收率76.8%。20g 6-demethyltetracycline is added in the 85% ethanol aqueous solution in 100g volume concentration, and 10g mass concentration is 48% hydrobromic acid aqueous solution in 35 ℃, throws into the autoclave of 500ml after dissolving, uses 0.2MPa Nitrogen replacement 3 times. Under the nitrogen of 2.0MPa, the temperature is controlled at 45~50°C, and the content of 6-desmethyltetracycline in the reaction solution is controlled to be 0.6%, the reaction is completed, and the nitrogen gas is released. The obtained reaction solution was cooled to 0°C, adjusted to pH 1 with 98% concentrated sulfuric acid, kept stirring for 2 hours, and filtered to obtain 42.0 g of wet cake. The wet filter cake was added to 60g of anhydrous methanol, 2.5g of DMF was added, the pH was adjusted to 7.3 with ammonia water, stirred at 5°C for 2h, filtered to obtain high-purity 6-desmethyl-6-anhydrotetracycline, and dried. 14.6 g of yellow powder were obtained with a purity of 95.6% and a yield of 76.8%.
实施例3:Example 3:
将100g软水降温至10℃,加入30g去甲金霉素盐酸盐,用氨水调节pH至7.8,搅拌全溶后加入35g尿素,搅拌10分钟后将上述混合液和0.7g 10%Pd/C(折干后)投入到500ml的氢化反应釜中。先后用0.2MPa的氮气和0.2MPa的氢气分别置换3次。在1.0MPa的氢气压力下,控温在35~40℃,反应6h,中控至反应液中的原料去甲基金霉素含量为0.9%,反应结束,泄氢气,氮气置换三次。放料,降温至5℃,滴加质量浓度为36%的浓盐酸16g,搅拌至物料完全溶解后,过滤Pd/C。收集滤液,滴加质量浓度为40%的液碱27.6g,于5℃保温析晶1h,抽滤,得6-去甲基四环素,烘干得22.4g,纯度96.8%,收率81.2%。Cool 100g of soft water to 10°C, add 30g of chlortetracycline hydrochloride, adjust the pH to 7.8 with ammonia, stir to dissolve completely, add 35g of urea, stir for 10 minutes, mix the above mixture and 0.7g of 10% Pd/C (After drying) put into a 500ml hydrogenation reactor. It was replaced three times with 0.2MPa nitrogen and 0.2MPa hydrogen respectively. Under the hydrogen pressure of 1.0 MPa, the temperature was controlled at 35~40 °C, and the reaction was carried out for 6 h, and the content of the raw material demethyl chlortetracycline in the reaction solution was controlled to be 0.9%. The material was discharged, cooled to 5°C, 16 g of concentrated hydrochloric acid with a mass concentration of 36% was added dropwise, stirred until the material was completely dissolved, and the Pd/C was filtered. The filtrate was collected, 27.6 g of liquid caustic soda with a mass concentration of 40% was added dropwise, crystallization was maintained at 5°C for 1 h, suction filtration was performed to obtain 6-desmethyltetracycline, and 22.4 g was obtained by drying, with a purity of 96.8% and a yield of 81.2%.
22.4g 6-去甲基四环素加入到100g体积浓度为85%的异丙醇水溶液中,35℃内加入11g 对甲苯磺酸,溶解后投到500ml的高压釜中,用0.2MPa的氮气置换3次。在3.0MPa的氮气下,控温在50~55℃,中控至反应液中原料6-去甲基四环素含量为0.87%,反应结束,泄氮气。将得到的反应液降温至-5℃,用98%浓硫酸调节pH到1,保温搅拌2h,过滤得湿料滤饼40.1g。湿料滤饼加入到60g无水甲醇中,加入3g DMF,再用氨水调节pH到7.6,-5℃下保温搅拌2h,过滤得高纯度6-去甲基-6-脱水四环素,烘干得15.1g黄色粉末,纯度94.8%,收率70.3%。22.4g of 6-demethyltetracycline was added to 100g of isopropanol aqueous solution with a volume concentration of 85%, 11g of p-toluenesulfonic acid was added at 35°C, and after dissolving, it was thrown into a 500ml autoclave, and replaced with 0.2MPa nitrogen for 3 Second-rate. Under the nitrogen gas of 3.0MPa, the temperature is controlled at 50~55°C, and the content of 6-desmethyltetracycline in the reaction solution is controlled to be 0.87%, the reaction is completed, and the nitrogen gas is released. The obtained reaction solution was cooled to -5°C, adjusted to pH 1 with 98% concentrated sulfuric acid, kept stirring for 2 hours, and filtered to obtain 40.1 g of wet cake. The wet filter cake was added to 60g of anhydrous methanol, 3g of DMF was added, the pH was adjusted to 7.6 with ammonia water, stirred at -5°C for 2h, filtered to obtain high-purity 6-desmethyl-6-anhydrotetracycline, and dried to obtain 15.1 g of yellow powder with a purity of 94.8% and a yield of 70.3%.
本说明书所述的内容仅仅是对发明构思实现形式的列举,本发明的保护范围不应当被视为仅限于实施例所陈述的具体形式。The content described in this specification is only an enumeration of the realization forms of the inventive concept, and the protection scope of the present invention should not be regarded as being limited to the specific forms stated in the embodiments.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010461654.XA CN111574392A (en) | 2020-05-27 | 2020-05-27 | A kind of preparation method of 6-desmethyl-6-anhydrotetracycline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010461654.XA CN111574392A (en) | 2020-05-27 | 2020-05-27 | A kind of preparation method of 6-desmethyl-6-anhydrotetracycline |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111574392A true CN111574392A (en) | 2020-08-25 |
Family
ID=72121683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010461654.XA Pending CN111574392A (en) | 2020-05-27 | 2020-05-27 | A kind of preparation method of 6-desmethyl-6-anhydrotetracycline |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111574392A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202449A (en) * | 1987-07-28 | 1993-04-13 | Nippon Kayaku Kabushiki Kaisha | Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline |
US20100305072A1 (en) * | 2006-12-21 | 2010-12-02 | Kim Oak K | Substituted Tetracycline Compounds |
CN106831479A (en) * | 2017-02-06 | 2017-06-13 | 福建省微生物研究所 | A kind of preparation method of minocycline hydrochloride |
-
2020
- 2020-05-27 CN CN202010461654.XA patent/CN111574392A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202449A (en) * | 1987-07-28 | 1993-04-13 | Nippon Kayaku Kabushiki Kaisha | Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline |
US20100305072A1 (en) * | 2006-12-21 | 2010-12-02 | Kim Oak K | Substituted Tetracycline Compounds |
CN106831479A (en) * | 2017-02-06 | 2017-06-13 | 福建省微生物研究所 | A kind of preparation method of minocycline hydrochloride |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014187364A1 (en) | Preparation method of trihydroxyethyl rutoside | |
CN109928982B (en) | Artemisinin separation and purification process | |
WO2015111085A2 (en) | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof | |
WO2009082913A1 (en) | Process for isolation of a mixture of rrrs and sssr configurations of nebivolol intermediates | |
CN111574392A (en) | A kind of preparation method of 6-desmethyl-6-anhydrotetracycline | |
CN115417883B (en) | Crystal form of rui Lu Geli and preparation method thereof | |
CN113185508A (en) | Method for preparing lurasidone with high purity and high yield | |
CN109824539B (en) | Novel method for synthesizing tigecycline from demethyl aureomycin | |
CN111393340B (en) | Green production method of bisphenol S | |
CN114539084B (en) | Preparation method of mirabegron and intermediate thereof | |
CN116239492A (en) | Continuous synthesis process of N-benzyl hydroxylamine hydrochloride | |
CN115557891A (en) | Preparation method of dextromethorphan | |
CN109651234B (en) | Synthesis method of donepezil hydrochloride | |
CN109280011B (en) | Synthesis method of OLED intermediate 2-bromopyrene | |
CN111100042B (en) | Preparation method of 2-methoxy-5-sulfonamide benzoic acid | |
CN111100121B (en) | Purification method of berberine or hydrochloride thereof | |
CN114516874A (en) | A kind of new crystal form of methotrexate and preparation method thereof | |
CN103387511B (en) | A kind of preparation method of Sancycline | |
CN114591236A (en) | A kind of improved preparation method of indacaterol | |
CN115536558B (en) | Refining process of bumetanide crude product | |
CN111100062A (en) | Synthesis method of donepezil hydrochloride | |
CN115181093B (en) | Preparation method of Sunvozertinib intermediate | |
CN107188884A (en) | A kind of purification process of pomalidomide | |
CN115925562B (en) | A kind of preparation method of salbutamol sulfate | |
CN112920054A (en) | Preparation method of 3,3 ', 4, 4' -tetraaminobiphenyl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200825 |
|
RJ01 | Rejection of invention patent application after publication |